Atopic Dermatitis
Conference Coverage
How does atopic dermatitis present in skin of color?
Morphological variants common in skin of color include the follicular variant or micropapular variant of AD.
From the Journals
Dust mite immunotherapy may help some with eczema
In a study, 74.2% and 58% of patients in HDM SLIT and placebo groups, respectively, showed at least a15-point decrease in SCORAD, but those...
Conference Coverage
Expert shares top five atopic dermatitis–related questions he fields
Counseling about systemic therapy includes shared decision-making, Dr. Lawrence F. Eichenfield says.
From the Journals
Association of height, BMI, and AD in young children may be transient
"The potential for 'catch up' in height for children with atopic dermatitis observed in our study may be explained with resolution of atopic...
Conference Coverage
Cannabinoids being studied for a variety of dermatologic conditions
Recent research shows that the endocannabinoid system is involved in modulation of the CNS and in immune function, particularly skin homeostasis...
From the Journals
More eczema in children exposed to toxic metals in utero
A wealth of previous research links arsenic exposure during adulthood to skin disease and immune dysfunction.
Latest News
Early peanut feeding guidelines still not reaching families
“Despite strong evidence that early introduction of peanut within the first year of life can prevent the development of peanut allergy, this...
Latest News
9-step ladder may kids with allergies return to eggs
Attempts to reintroduce egg into the child’s diet can start at the age of 12 months or 6 months from the last reaction.
Conference Coverage
Extension study finds dupilumab effective for up to 1 year in teens with AD
At 52 weeks, 37% of 52 patients with weights under 60 kg reached an Investigator Global Assessment of 0/1, a level that had been fairly steady...
Conference Coverage
Management of pediatric food allergies evolving
“Once you just get them on the right [regimen], they don’t need to be cutting the food out of their diet. It’s just making their life...
News
FDA approves topical ruxolitinib for atopic dermatitis, first JAK inhibitor for this indication in the U.S.
“Approval of topical ruxolitinib fills a major gap in the treatment of atopic dermatitis: a safe, effective, and tolerable non-steroidal topical...